OTC: SYGGF - Synairgen plc

Yield per half year: -47.83%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Synairgen plc


About Synairgen plc

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease. The company was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.


Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета gbp
Сайт https://www.synairgen.com
Цена ао 0.013
Change price per day: 0% (0.012)
Change price per week: +20% (0.01)
Change price per month: -7.69% (0.013)
Change price per 3 month: -52% (0.025)
Change price per half year: -47.83% (0.023)
Change price per year: -76.47% (0.051)
Change price per 3 year: -96.03% (0.302)
Change price per year to date: -63.64% (0.033)

Underestimation

Title Value Grade
P/S 0 0
P/BV 0.8498 9
P/E 0 0
EV/EBITDA -0.0235 0
Total: 3.63

Efficiency

Title Value Grade
ROA, % -59.12 0
ROE, % -66.43 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 9.6

Growth impulse

Title Value Grade
Yield Revenue, % -32.26 0
Yield Ebitda, % 120.76 10
Yield EPS, % -23.11 0
Total: 6

Institutions Volume Share, %
Schwab Capital Trust-Laudus International Market Masters Fund 207041 0.1



Head Job title Payment Year of birth
Mr. Richard Marsden CEO, MD & Executive Director 412.77k 1967 (58 years)
Prof. Stephen T. Holgate CBE, M.D. Co-Founder, Non-Executive Director & Member of Scientific Advisory Board 55.37k 1947 (78 years)
Dr. Phillip David Monk Chairman of Scientific Advisory Board, Chief Scientific Officer & Executive Director 302.03k 1969 (56 years)
Prof. Donna Davies Co-Founder & Member of Scientific Advisory Board N/A
Prof. Ratko Djukanovic Co-Founder & Member of Scientific Advisory Board N/A
Mr. Joseph Tregonning Colliver F.C.A. CFO & Executive Director N/A 1980 (45 years)
Dr. Gareth E. Walters Ph.D. Chief Regulatory Officer N/A 1959 (66 years)
Ms. Jody Brookes Senior VP & Head of Clinical Operations N/A
Mr. Richard Francis Senior VP and Head of CMC & Quality N/A
Dr. Victoria Tear Head of Laboratory N/A

Address: United Kingdom, Southampton, Mailpoint 810 - open in Google maps, open in Yandex maps
Website: https://www.synairgen.com